Secondary Neoplasm — Trials

Secondary Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

14,673 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1,301–1,304 of 1,304 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03836352	Study of an Immunotherapeutic, DPX-Survivac, in Combination With Low Dose Cyclophosphamide & Pembrolizumab, in Subjects With Selected Advanced & Recurrent Solid Tumors	active not recruiting	Phase 2	184	ImmunoVaccine Technologies, Inc. (IMV Inc.)INDUSTRY	2	Mar 31, 2022	clinicaltrials
NCT03308396	Study of Durvalumab and Guadecitabine in Advanced Kidney Cancer	active not recruiting	Phase 1 / Phase 2	57	Ajjai Alva, MDOTHER	1	Feb 17, 2022